And now, a seaweed-based nutraceutical cure for fatty liver disease

Pre-clinical trials show no evidence of side effects in the product, which is the ninth such to be developed from marine organisms by Kochi-based CMFRI


Photo: Shutterstock

BS Reporter New Delhi
The Central Marine Fisheries Research Institute (CMFRI) based in Kochi has come up with a nutraceutical product from select seaweeds to treatment of non-alcoholic fatty liver disease (NAFLD). Named Cadalmin LivCure extract, the product is a unique blend of 100 per cent natural bioactive ingredients extracted from seaweeds to improve liver health. 

This is the ninth such product from marine organisms being developed by the CMFRI, which works under the Indian Council of Agriculture Research (ICAR). The umbrella organisation had already brought out nutraceuticals to combat a series of lifestyle diseases such as type-2 diabetes, arthritis, cholesterol, hypertension, hypothyroidism and osteoporosis, and to improve immunity. Out of these nutraceuticals, eight products are from seaweeds and one from green mussel.


First Published: Sep 27 2022 | 7:22 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to